Tango Therapeutics (TNGX) Capital Expenditures (QoQ) (2021 - 2026)
Tango Therapeutics (TNGX) Capital Expenditures (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tango Therapeutics | 3.94 Bn | 3.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.99% |
| Dec 31, 2025 | 191.67% |
| Sep 30, 2025 | -132.94% |
| Jun 30, 2025 | 400.00% |
| Mar 31, 2025 | -93.53% |
| Dec 31, 2024 | 243.53% |
| Sep 30, 2024 | -199.82% |
| Jun 30, 2024 | 1,671.43% |
| Mar 31, 2024 | 97.23% |
| Dec 31, 2023 | -7,987.50% |
| Sep 30, 2023 | -97.59% |
| Jun 30, 2023 | 7.10% |
| Mar 31, 2023 | -40.44% |
| Dec 31, 2022 | -84.37% |
| Sep 30, 2022 | 1,410.83% |
| Jun 30, 2022 | -201.60% |
| Mar 31, 2022 | 290.11% |
| Dec 31, 2021 | -161.16% |
| Sep 30, 2021 | 341.57% |
| Jun 30, 2021 | -207.88% |